WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2023> 39> 2

Volume: 39 Issue: 2

1. Advances in the experimental research on traditional Chinese medicine against liver fibrosis Page:249—259
2. Advances and thoughts in traditional Chinese medicine diagnosis and treatment of chronic hepatitis B-related liver fibrosis Page:260—266
3. Advantages and characteristics of traditional Chinese medicine in the treatment of liver fibrosis Page:267—272
4. Blocking and reversing liver fibrosis with traditional Chinese medicine compound prescriptions: Beyond the known frontiers Page:273—277
5. Association between liver fibrosis and gut microbiota based on "harmonizing liver and spleen" Page:278—283
6. ｜Identification of liver fibrosis-related microRNAs in human primary hepatic stellate cells using high-throughput sequencing Page:283—283
7. Advances in integrated traditional Chinese and Western medicine diagnosis and treatment of hepatic fibrosis Page:284—289
8. Predictive factors for functional cure after sequential therapy with nucleos(t)ide analogues and pegylated interferon alfa-2b in treatment of chronic hepatitis B Page:299—306
9. Value of indocyanine green clearance test combined with total bilirubin actual resident rate in evaluating the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure after artificial liver support system therapy Page:307—315
10. Effect of cyclin D1 on HBV transcription and replication Page:316—324
11. Prevalence of primary biliary cholangitis in the Chinese general population and its influencing factors: A systematic review Page:325—332
12. Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with portal hypertension Page:333—338
13. Value of blood ammonia and cholinesterase in the early diagnosis of liver cirrhosis with minimal hepatic encephalopathy Page:339—344
14. Effect of traditional Chinese medicine on portal vein thrombosis in patients with liver cirrhosis and its medication characteristics Page:345—351
15. Distribution of traditional Chinese medicine syndrome types and elements in liver cirrhosis patients with dysplastic nodules: An analysis of 138 cases Page:352—358
16. Influencing factors for acute kidney injury in acute liver failure and establishment of a predictive model Page:359—364
17. Clinical features of myeloproliferative neoplasms with portal hypertension as the main manifestation Page:365—369
18. Value of endoscopic ultrasonography in the diagnosis of muddy stones of the common bile duct Page:370—375
19. Effect of Dahuang Lingxian prescription on the scf/c-kit signaling pathway in gallbladder interstitial cells of Cajal in a guinea pig model of cholesterol gallstone Page:376—382
20. A case of idiopathic portal hypertension with psoriasis Page:383—386
21. Report and genetic analysis of autoimmune liver diseases between mother and daughter Page:387—391
22. Klebsiella pneumoniae liver abscess in a patient with selective IgA deficiency Page:392—396
23. A case report of successful diagnosis and treatment of hepatic sinusoidal obstruction syndrome Page:397—400
24. Association of dietary behavior with nonalcoholic fatty liver disease Page:401—407
25. Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease Page:408—412
26. Research advances in nanomedicine in treatment of liver fibrosis Page:413—418
27. Association between liver sinusoidal endothelial cells and liver fibrosis Page:419—423
28. Advances in minimally invasive treatment of upper gastrointestinal bleeding in liver cirrhosis Page:424—431
29. Biological connotation of "phlegm-turbidity" theory in hepatocellular carcinoma microenvironment based on abnormal lipid metabolism Page:432—438
30. From viral hepatitis to hepatocellular carcinoma: The role of exosomal microRNAs Page:439—443
31. Research advances in myosteatosis in chronic liver diseases Page:444—449
32. Research advances in congenital extrahepatic portosystemic shunt Page:450—456
33. Advances in the application of three-dimensional visualization technique in hepatic alveolar echinococcosis Page:457—462
34. Research advances in immune checkpoint inhibitor-related cholangitis Page:463—468
35. Role of tumor-associated macrophages in cholangiocarcinoma Page:469—473
36. Pathogenesis of delayed gastric emptying after pancreaticoduodenectomy and related risk factors Page:474—480

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.